Insight change in psychosis: Relationship with neurocognition, social cognition, clinical symptoms and phase of illness

Acta Psychiatrica Scandinavica

Volumn 129, Issue 2, 2014, Pages 126-133

  Quee, P J ^a,b   van der Meer, L ^b,c   Krabbendam, L ^d   de Haan, L ^e   Cahn, W ^f   Wiersma, D ^a   van Beveren, N ^g   Pijnenborg, G H M ^h,i   Mulder, C L ^j   Bruggeman, R ^a   Aleman, A ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Lentis Center for Mental Health   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g Delta Center for Mental Health Care   (Netherlands)

^h UNIVERSITY OF GRONINGEN   (Netherlands)

ⁱ NONE   (Netherlands)

^j ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Awareness; GROUP longitudinal; Insight; Neuropsychology; Schizophrenia

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BIRCHWOOD INSIGHT SCALE; CLINICAL ASSESSMENT; FEMALE; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOCIAL COGNITION; VULNERABLE POPULATION; YOUNG ADULT;

AWARENESS; GROUP-LONGITUDINAL; INSIGHT; NEUROPSYCHOLOGY; SCHIZOPHRENIA;

ADULT; AWARENESS; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR; SOCIAL PERCEPTION; YOUNG ADULT;

EID: 84891834650     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12138     Document Type: Article

References (35)

1. Amador XF, Gorman JM. Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am 1998;21:27-42.
2. Roe D, Kravetz S. Different ways of being aware of psychiatric disability: a multifunctional narrative approach to insight into mental disorder. J Nerv Ment Dis 2003;191:417-424.
3. David AS. Insight and psychosis. Br J Psychiatry 1990;156:798-808.
4. Jónsdóttir H, Opjordsmoen S, Birkenaes AB et al. Predictors of medication adherence in patients with schizophrenia or bipolar disorder. Acta Psychiatr Scand 2013;127:23-33.
5. Ruissen AM, Widdershoven GA, Meynen G, Abma TA, van Balkom AJ. A systematic review of the literature about competence and poor insight. Acta Psychiatr Scand 2012;125:103-113.
6. Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW. Insight as a predictor of the outcome in first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry 2007;68:81-86.
7. Aleman A, Agrawal N, Morgan KD, David AS. Insight in psychosis and neuropsychological function: a meta-analysis. Br J Psychiatry 2006;189:204-212.
8. Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res 2003;61:75-88.
9. Parellada M, Boada L, Fraquas D et al. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull 2011;37:38-51.
10. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitivefactors in schizophrenia. Schizophr Res 2004;72:29-39.
11. Cuesta MJ, Peralta V, Zarzuela A, Zandio M. Insight dimensions and cognitive function in psychosis: a longitudinal study. BMC Psychiatry 2006;31:26.
12. Cuesta MJ, Peralta V, Compos MS, Garcia-Jalon E. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample. Schizophr Res 2011;130:148-156.
13. Lysaker PH, Clements CA, Plascak-Hallberg CD, Knipscheer SJ, Wright DE. Insight and personal narratives of illness in schizophrenia. Psychiatry 2002;65:197-206.
14. Quee PJ, van der Meer L, Bruggeman R et al. Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. Schizophr Bull 2011;37:29-37.
15. Buchy L, Bodnar M, Malla A, Joober R, Lepage M. A 12-month outcome study of insight and symptom change in first-episode psychosis. Early Interv Psychiatry 2012;4:79-88.
16. Korver N, Quee PJ, Boos HB, Simons CJ, De Haan L, Group Investigators. Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 2012;21:205-221.
17. Andreasen NC, Flaum MC, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatr 1992;49:615-623.
18. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for Schizophrenia. Schizophr Bull 1987;13:261-276.
19. Birchwood M, Smith J, Drury V, Healy J. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand 1994;89:62-67.
20. Meijer J, Simons CJP, Quee PJ, Verweij K, Group Investigators. Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents. Acta Psychiatr Scan 2011;125:66-76.
21. Blyler CR, Gold JM, Iannone VN, Buchanan RW. Short form of the WAIS-III for use with patients with schizophrenia. Schizophr Res 2000;46:209-215.
22. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112:201-210.
23. Verhage F. Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum, 1964.
24. Hilti CC, Hilti LM, Heinemann D, Robbins T, Seifritz E, Cattapan-Ludewig K. Impaired performance on the Rapid Visual Information Processing task (RVIP) could be an endophenotype of schizophrenia. Psychiatr Res 2010;177:60-64.
25. Van't Wout M, Alemana A, Kessels RPC, Larøi F, Kahn RS. Emotional processing in a non-clinical psychosis-prone sample. Schizophr Res 2004;68:271-281.
26. Corcoran R, Mercer G, Frith CD. Schizophrenia, symptomatology and social influence: investigating 'theory of mind' in people with schizophrenia. Schizophr Res 1995;17:5-13.
27. Andreasen NC, Carpenter WT jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in Schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441-449.
28. Pijnenborg GHM, Donkersgoed R, David AT, Aleman A. Changes in insight during treatment for psychotic disorders: a meta-analysis. Schizophr Res 2012;144:109-117.
29. Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull 2011;37(Suppl. 2):S41-S54.
30. Lysaker PH, Buck KD. Neurocognitive deficits as a barrier to psychosocial function in schizophrenia: effects on learning, coping, & self-concept. J Psychosoc Nurs Ment Health Serv 2007;45:24-30.
31. Koren D, Seidman LJ, Poyurovsky M et al. The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res 2004;70:195-202.
32. Pru L, Wiedl KH, Waldorf M. Stigma as a predictor of insight in schizophrenia. Psychiatry Res 2012;198:187-193.
33. Schennach-Wolff R, Obermeier M, Seemüller F et al. Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale. Acta Psychiatr Scand 2011;123:228-238.
34. Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry 1996;169:444-450.
35. Pijnenborg GH, van der Gaag M, Bockting CL, van der Meer L, Aleman A. REFLEX, a social-cognitive group treatment to improve insight in schizophrenia: study protocol of a multi-center RCT. BMC Psychiatry 2011;5:161.